Ovia Health, a clinically-backed, digital family health platform, today announced the launch of a new birth control tracking feature on the Ovia Fertility mobile app in collaboration with Nurx, a healthcare service providing hassle-free access to birth control and emergency contraceptives. The new feature is designed to help women stay on top of their preferred method of birth control, and it allows users…
Femtech company Clue, known for its pioneering period tracking app that initially launched in 2013, has raised an additional €16M in funding led by Balderton Capital and Future Positive Capital. The new funds will support commercialization of the company’s recently FDA-approved app-based digital contraceptive, team growth as well as new product development. Previous investors NGP Capital, Union Square Ventures, Atlantic Labs, Adjacent,…
Univfy, a company using artificial intelligence (AI) and machine learning (ML) to personalize counseling and increase access to fertility care, has announced that it raised $6M of its Series B funding round led by a portfolio company of Atlantic Street Capital. The Univfy AI Platform empowers individuals with personalized information and counseling to inform smarter spending and decision-making. Based on proprietary technology developed at Stanford University,…
Eggschain is a healthcare technology company and thought leader in the fertility, health tech, family-building and cryogenic preservation industries. Patent-granted and cloud-based, Eggschain is the first blockchain-integrated inventory management and chain of custody technology for tracking biospecimens, including sperm, eggs, embryos, genome, stem cell, tissues and organs, and other genetic material. In partnership with several of the world’s leading experts in reproductive…
Reproductive health company Proov has raised a $9.7M Series A led by Hambrecht Ducera Growth Venture to invest in its newly launched “Complete” product. Other participants in the round include SteelSky Ventures, WCC Partners, LightShip Capital, GingerBread Capital, and Portfolia Proov is known for its PdG test and associated patented protocol, that lets women confirm ovulation quality, which pertains to when ovulation…
EMD Serono, the biopharmaceutical business of German Merck KGaA in the U.S. and Canada, has launched Fertility LifeLines, a patient support program, based on input from reproductive health medical professionals and patients on their fertility journey. The new Fertility LifeLines portal combines all patient support aspects – from financial assistance and access to resources, to the ability to contact live support staff – within a single…
Reproductive Health startup OvaryIt is launching the OvaryIt Foundation, a Not-for-Profit with a mission to increase access to contraceptive and family planning services and advance women’s health through Education, Research, and Advocacy. The Foundation has established partnerships with leading domestic violence shelters, anti-human trafficking organizations and is currently working to build relationships with re-entry programs for those released from incarceration. In addition,…
Schrödinger, whose physics-based software platform is transforming the way therapeutics and materials are discovered, has been awarded a two-year, $4.9M grant from the Bill & Melinda Gates Foundation to support a global women’s health initiative. The grant is part of a Gates Foundation initiative aimed at accelerating emerging opportunities to advance the field of contraceptive drug discovery. The emphasis of this initiative…
